Follow
Morse Faria
Morse Faria
PPD
Verified email at ppdi.com
Title
Cited by
Cited by
Year
Comparison of a stable isotope labeled (SIL) peptide and an extended SIL peptide as internal standards to track digestion variability of an unstable signature peptide during …
M Faria, MS Halquist, M Yuan, W Mylott Jr, RG Jenkins, HT Karnes
Journal of Chromatography B 1001, 156-168, 2015
532015
Multiplex LC-MS/MS assays for clinical bioanalysis of MEDI4276, an antibody-drug conjugate of tubulysin analogue attached via cleavable linker to a biparatopic humanized …
M Faria, M Peay, B Lam, E Ma, M Yuan, M Waldron, WR Mylott Jr, M Liang, ...
Antibodies 8 (1), 11, 2019
432019
Multifaceted bioanalytical methods for the comprehensive pharmacokinetic and catabolic assessment of MEDI3726, an anti-prostate-specific membrane antigen pyrrolobenzodiazepine …
Y Huang, CJ Del Nagro, K Balic, WR Mylott Jr, OA Ismaiel, E Ma, M Faria, ...
Analytical Chemistry 92 (16), 11135-11144, 2020
162020
An extended stable isotope‐labeled signature peptide internal standard for tracking immunocapture of human plasma osteopontin for LC‐MS/MS quantification
M Faria, MS Halquist, M Yuan, W Mylott Jr, RG Jenkins, HT Karnes
Biomedical Chromatography 29 (11), 1780-1782, 2015
122015
Nanotechnology in cancer: A clinical review
O Agrawal, R Brahme, M Faria, S Shidhaye
Journal of Applied Pharmaceutical Science, 25-29, 2011
122011
Liquid chromatography–tandem mass spectrometry method for quantification of thymidine kinase activity in human serum by monitoring the conversion of 3′-deoxy-3 …
M Faria, MS Halquist, E Kindt, W Li, HT Karnes, PJ O’Brien
Journal of Chromatography B 907, 13-20, 2012
112012
Internal standards for absolute quantification of large molecules (proteins) from biological matrices by LC-MS/MS
M Faria, MS Halquist
Calibration Valid. Anal. Methods A Sampl. Curr. Approaches 61, 2018
82018
Immunoaffinity LC–MS/MS to quantify a PEGylated anti-Factor D Fab biotherapeutic in cynomolgus monkey serum
L Liu, Y Liu, L Dai, C Stella, M Faria, J Shao, JL Hicks, DF Cortes, ...
Bioanalysis 11 (23), 2161-2173, 2019
72019
Peptides and Oligonucleotide-Based Therapy: Bioanalytical Challenges and Practical Solutions
R Boyanapalli, I Singh, M Faria
An Introduction to Bioanalysis of Biopharmaceuticals, 131-155, 2022
12022
Quantitative mass spectrometric investigations of protein biomarkers: Serum thymidine kinase 1 and human osteopontin
M Faria
Virginia Commonwealth University, 2014
12014
HPLC fingerprinting of fenugreek seeds using trigonelline as a biomarker
H PD, M Faria
Indian Drugs 45, 12, 2008
12008
An Introduction to Bioanalysis of Antibody-Drug Conjugates
M Faria, V Ramani, S Kumar
An Introduction to Bioanalysis of Biopharmaceuticals, 49-74, 2022
2022
Liquid Chromatography and Tandem Mass Spectrometry Method for the Quantitative Determination of Tanespimycin and its Active Metabolite in Human Plasma: Method Validation and …
M Faria, OA Ismaiel, J Waltrip, T Mariannino, M Yuan, W Mylott, ...
2020
LC-MS/MS Method for the Quantitative Determination of Tanespimycin and its Active Metabolite in Human Plasma: Method Validation and Overcoming an Insidious APCI Source Phenomenon
M Faria, OA Ismaiel, J Waltrip, T Mariannino, M Yuan, W Mylott, ...
J Appl Bioanal 6 (3), 145-163, 2020
2020
Addressing Bioanalytical Needs of Antibody-Based Biothera-peutics by LC-MS
M Faria
J Appl Bioanal 6 (1), 7-11, 2020
2020
A simplified approach to measuring thymidine kinase activity in cells, tumors, and blood as a biomarker of tumor proliferative potential
W Li, X Kang, KE Kindt, C Zhang, M Spilker, PJ Berlinski, M Eisenbraun, ...
Cancer Research 72 (8_Supplement), 2841-2841, 2012
2012
Quantification of Human Osteopontin, a Cancer Biomarker Protein from Plasma by Immunoaffinity and Microflow LC-MS/MS
M Faria, MS Halquist, M Yuan, W Mylott Jr, RG Jenkins, HT Karnes
A Simplified Approach to Measuring Thymidine Kinase Activity in Cultured Cells, Tumors, and Blood as a Biomarker of Tumor Proliferative Potential 2841
W Li, E Kindt, X Kang, P Berlinski, M Eisenbraun, M Elliott, JA Arbuckle, ...
Quantitative Mass Spectrometric Evaluation of Human Osteopontin, an Inflammation Biomarker Protein Using a Biologically Relevant Tryptic Signature Peptide
M Faria, MS Halquist, HT Karnes
The system can't perform the operation now. Try again later.
Articles 1–19